United States· US:0032-1203_94463229-9296-4640-854f-41d76386d312
Creon
A medicinal product containing pancrelipase amylase; pancrelipase lipase; pancrelipase protease, registered in United States by AbbVie Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
- Manufacturer
- AbbVie Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 19, 2026
Packs & prices · 2
- ndc110032-1203-64
- ndc110032-1203-70
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4a8de8d-ae09-4c89-8393-92e0d3d973fe GET /v1/drugs/e4a8de8d-ae09-4c89-8393-92e0d3d973fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "15000; 3000; 9500",
"substance": "PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE",
"productndc": "0032-1203",
"dosage_form": "CAPSULE, DELAYED RELEASE",
"dea_schedule": null,
"strength_unit": "[USP'U]/1; [USP'U]/1; [USP'U]/1",
"application_number": "BLA020725",
"marketing_category": "BLA"
}See everything about pancrelipase amylase; pancrelipase lipase; pancrelipase protease.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.